Vantage Point: It's time to talk honestly about dying
A Stanford palliative-care expert urges better, higher-quality communication between patients and physicians regarding end-of-life care.
Using Apple HealthKit to care for patients with Type 1 diabetes
Rajiv Kumar began piloting HealthKit in March with 10 patients to assess its ability to track blood-sugar levels.
Dangerous liaison: Bacteria, viruses in league
Serendipity spurs the discovery of a curious collusion between bacterial pathogens and viruses that infect them, triggering the formation of clinically frustrating structures called biofilms.
Deisseroth wins $3 million Breakthrough Prize
Initiated in 2013 by Silicon Valley entrepreneurs, the annual award — the world’s largest in dollar terms — honors pioneers in life sciences, fundamental physics and mathematics.
Stanford Medicine debuts compelling new formats for continuing medical education
The medical school is debuting new online continuing medical education courses that show how information freed from words-only presentation can be an effective medical education tool.
Rocket scientists bring expertise to analyzing breath of sick children
Three rocket-combustion experts teamed up with a pediatrician to engineer a breath analyzer for diseases — a goal that many have tried and failed to reach.
Story of family's tumor donation inspires more donations
With the donated tissue, a Stanford team has created the first cell line and mouse model of diffuse intrinsic pontine glioma, a deadly tumor.
Bad for the bone: The toll of childhood chronic disease
A Stanford researcher is working to prevent early osteoporotic fractures in those who have withstood childhood chronic diseases.
Byerwalter to serve as interim president and CEO of Stanford Health Care
Mariann Byerwalter has a long history of service and commitment to the Stanford community.
Researchers urge lifting of NIH funding restrictions on chimeric research
In September, the National Institutes of Health halted research funding for chimeric human/nonhuman embryos until new funding guidelines are established. Stanford researchers describe the detrimental impact of a ban.
Leading in Precision Health
Stanford Medicine is leading the biomedical revolution in precision health, defining and developing the next generation of care that is proactive, predictive and precise.
A Legacy of Innovation
Stanford Medicine's unrivaled atmosphere of breakthrough thinking and interdisciplinary collaboration has fueled a long history of achievements.